Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.54 PLN | +0.28% | +1.14% | -0.84% |
Mar. 28 | BIOTON S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | BIOTON S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 | CI |
Valuation
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Capitalization 1 | 434.5 | 326.3 | 367.5 | 359.3 | 289.4 | 306.5 |
Enterprise Value (EV) 1 | 538.4 | 446.5 | 455.3 | 460.6 | 356.4 | 371.3 |
P/E ratio | 16.5 x | -2.57 x | 11 x | 140 x | 204 x | 135 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 1.8 x | 1.62 x | 1.66 x | 2.2 x | 1.24 x | 1.69 x |
EV / Revenue | 2.23 x | 2.21 x | 2.05 x | 2.82 x | 1.53 x | 2.04 x |
EV / EBITDA | -19.8 x | 30.2 x | 5.39 x | 11.2 x | 7.15 x | 17.8 x |
EV / FCF | 37.3 x | 28.1 x | 16.1 x | -32.3 x | 10.2 x | -38.9 x |
FCF Yield | 2.68% | 3.56% | 6.22% | -3.1% | 9.82% | -2.57% |
Price to Book | 0.61 x | 0.56 x | 0.6 x | 0.58 x | 0.48 x | 0.51 x |
Nbr of stocks (in thousands) | 85,864 | 85,864 | 84,864 | 85,864 | 85,864 | 85,864 |
Reference price 2 | 5.060 | 3.800 | 4.330 | 4.185 | 3.370 | 3.570 |
Announcement Date | 4/30/19 | 4/14/20 | 4/15/21 | 3/31/22 | 3/31/23 | 3/28/24 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net sales 1 | 241.2 | 202 | 221.8 | 163 | 233.2 | 181.6 |
EBITDA 1 | -27.22 | 14.78 | 84.46 | 41.08 | 49.87 | 20.88 |
EBIT 1 | -54 | -13.67 | 55.31 | 13.45 | 24.15 | -3.723 |
Operating Margin | -22.39% | -6.77% | 24.94% | 8.25% | 10.36% | -2.05% |
Earnings before Tax (EBT) 1 | 15.17 | -162.1 | 41.61 | 8.331 | 4.952 | 7.234 |
Net income 1 | 26.27 | -126.7 | 33.92 | 2.882 | 1.421 | 2.275 |
Net margin | 10.89% | -62.71% | 15.29% | 1.77% | 0.61% | 1.25% |
EPS 2 | 0.3059 | -1.480 | 0.3950 | 0.0300 | 0.0165 | 0.0265 |
Free Cash Flow 1 | 14.42 | 15.91 | 28.32 | -14.28 | 35.01 | -9.546 |
FCF margin | 5.98% | 7.87% | 12.77% | -8.76% | 15.02% | -5.26% |
FCF Conversion (EBITDA) | - | 107.6% | 33.53% | - | 70.21% | - |
FCF Conversion (Net income) | 54.89% | - | 83.49% | - | 2,463.97% | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/30/19 | 4/14/20 | 4/15/21 | 3/31/22 | 3/31/23 | 3/28/24 |
Balance Sheet Analysis
Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|
Net Debt 1 | 104 | 120 | 87.9 | 101 | 67.1 | 64.8 |
Net Cash position 1 | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | -3.816 x | 8.134 x | 1.04 x | 2.464 x | 1.345 x | 3.104 x |
Free Cash Flow 1 | 14.4 | 15.9 | 28.3 | -14.3 | 35 | -9.55 |
ROE (net income / shareholders' equity) | 3.61% | -19.6% | 5.63% | 0.46% | 0.23% | 0.38% |
ROA (Net income/ Total Assets) | -3.2% | -0.9% | 3.95% | 0.97% | 1.82% | -0.29% |
Assets 1 | -820.2 | 14,024 | 859.6 | 296.9 | 78.06 | -797.4 |
Book Value Per Share 2 | 8.300 | 6.780 | 7.220 | 7.250 | 7.060 | 7.060 |
Cash Flow per Share 2 | 0.0900 | 0.0800 | 0.2600 | 0.1000 | 0.1100 | 0.0500 |
Capex 1 | 43.4 | 53.5 | 4.68 | 12.9 | 29.6 | 44.2 |
Capex / Sales | 18.02% | 26.46% | 2.11% | 7.91% | 12.69% | 24.32% |
Announcement Date | 4/30/19 | 4/14/20 | 4/15/21 | 3/31/22 | 3/31/23 | 3/28/24 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-0.84% | 74.8M | |
-1.17% | 104B | |
+2.87% | 97.47B | |
+4.95% | 22.25B | |
-14.77% | 21.68B | |
-8.63% | 18.2B | |
-39.98% | 17.02B | |
-13.21% | 16.36B | |
+8.55% | 14.39B | |
+35.75% | 12.37B |
- Stock Market
- Equities
- BIO Stock
- Financials BIOTON S.A.